Report Fraud About Us What We Do

Consumer News

Epilepsy Drug Recalled After Contamination Discovered

One lot of epilepsy and bipolar disorder tablets has been recalled after a cross-contamination with a drug used in heart and blood pressure medication was discovered, according to the FDA.

The epilepsy and bipolar medication is Lamotrigine 100mg. Lamotrigine is also sold under the brand name Lamictal brand. The lot under recall is No. 331771 with an expiration date of June 2021. The medication is sold in 100-count bottles.

The medications were manufactured by Taro Pharmaceutical Industries out of Haifa Bay, Israel and distributed by Taro Pharmaceuticals USA. The recall was made by the latter.

Do you have additional information about this recall? Are there other recalls we should cover? Tell us in the comments below. You can also contact us for more information! Feel free to shoot us an email to Outreach@ConsiderTheConsumer.com. You can also find us on TwitterFacebook, InstagramLinkedIn, or even connect with us directly on our website!

Similarly, please check out our current list of Class Actions and Class Action Investigations, here.

Interested in articles like these? Become a subscriber below!

About the Author: Aisha K. Staggers is a writer, lecturer, political analyst and literary agent. She appears weekly for “Staggers’ State of Things” on the Dr. Vibe Show. Her work has been published by Paper Magazine, AfroPunk, The Spool, GREY Journal, MTV News, HuffPost, Blavity, Atlanta Blackstar, For Harriet, New York Review of Books and a host of other first-run publications and syndicated outlets. Find her on Twitter @AishaStaggers. For more of her work, check out her page here!

Interested in posts like these? Stay up to date with our newsletter!

No thoughts on “Epilepsy Drug Recalled After Contamination Discovered” yet. Be the first to speak your mind!

Leave a Reply